VRDN

Viridian Therapeutics, Inc. is a biopharmaceutical company focused on advancing innovative therapies for patients with severe diseases, particularly in the areas of rare and autoimmune disorders. Headquartered in Boulder, Colorado, the company leverages cutting-edge research and development to create breakthrough treatments that address unmet medical needs. With a robust pipeline of candidates and a commitment to improving patient outcomes, Viridian is well-positioned to make significant contributions to the therapeutic landscape.